China
· Delayed Price · Currency is CNY Tonghua Dongbao Pharmaceutical Company Description
Tonghua Dongbao Pharmaceutical Co., Ltd. researches and develops, manufactures, and sells pharmaceutical for the treatment of diabetes, endocrine, and cardiovascular and cerebrovascular diseases products in China.
It offers human insulin API and injections; insulin glargine API and injections; insulin aspart API and injections; liraglutide injections; zhennaoning capsules; and diabetes-related medical devices.
The company also provides insulin pen and needle injection system, blood sugar monitoring system, and online and offline patient management system.
In addition, it offers chemical drugs, such as repaglinide and empagliflozin tablets. Further, the company offers building materials, including plastic steel windows and profiles; and engages in the real estate industry.
Tonghua Dongbao Pharmaceutical Co., Ltd. was founded in 1985 and is headquartered in Tonghua, China.
| Country | China |
| Founded | 1985 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 3,196 |
| CEO | Sheng Leng Chun |
Contact Details
Address: Dongbao New Village Tonghua, 134123 China | |
| Phone | 86 43 5508 8025 |
| Website | thdb.com |
Stock Details
| Ticker Symbol | 600867 |
| Exchange | Shanghai Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE000000H87 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Sheng Leng Chun | GM and Director |
| Junyu Chi | Chief Accountant |
| Hong Chen | Chief Engineer and Deputy GM |
| Guodong Zhang | Deputy GM and Director |
| Wenhai Zhang | Deputy GM and Director |
| Zhiqiang Du | Deputy General Manager |
| Fan Su | Deputy GM and Board Secretary |